Results demonstrate the utility of in vivo 31P NMR to detect significant alterations in phosphorylated nucleotides and phosphometabolites at specific developmental stages during medaka development and that late-stage medaka utilize PCr to generate ATP under hypoxic conditions.
At no time during the switch from 'normal' to 'compensated' and then to 'progressive' remodelling did we detect significant alterations in collagen, expressed exclusively by the NM population.
As we were able to detect significant alterations in metabolites in the bone marrow microenvironment, we investigated whether similar changes could be observed in the peripheral plasma (patient cohort information: Supplementary Table 2).
With agents of unknown, and perhaps only modest effects on susceptibility, an inoculum size of 1 is50 is optimal for providing maximum statistical power to detect significant alterations in susceptibility.
Interestingly, we did not detect significant alterations in the serum levels of the cytokines IL-10 and IL-1β, indicating that not all inflammatory mediators were equally affected by Smpdl3b deficiency.
In the present study, although the expressions of TAP-1, LMP-7, and tapasin were downregulated or lost in HER2 high-expressing TE4 in comparison to HER2 low-expressing TE1, we could not detect significant alterations in the expressions of LMP2, LMP7, Tap1, and tapasin between ESCC treated with HER2-siRNA and the control.
It is noteworthy that we failed to detect significant alterations for DC development and maturation in both Stat4−/− and Stat6−/− mice (data not shown).
